Role of Ormeloxifene in abnormal uterine bleeding
Phase 3
Completed
- Conditions
- Health Condition 1: - Health Condition 2: N800- Endometriosis of uterus
- Registration Number
- CTRI/2018/12/016561
- Lead Sponsor
- GMCH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 59
Inclusion Criteria
ALL WOMEN IN REPRODUCTIVE AND PERIMENOPAUSAL AGE GROUP PRESENTING WITH AUB
Exclusion Criteria
women with bulky uterus presenting with pressure symptoms.
submucosal fibroid
endometrial hyperplasia and polyp, complex adnexal mass, acute aub requiring immediate surgical intervention, coagulopathy, systemic disease, history of breast malignancy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PABC score to assess menstrual blood lossTimepoint: end of 3rd and 6th month
- Secondary Outcome Measures
Name Time Method effect of dysmenorrhoes, menstrual periodicity, side effects, hemoglobinTimepoint: end of 3rd and 6th month